隐源性非硬化性门脉高压症患者临床和肝组织病理学表现

doi:10.3969/j.issn.1672-5069.2018.03.002

实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (3): 325-328.doi: 10.3969/j.issn.1672-5069.2018.03.002

隐源性非硬化性门脉高压症患者临床和肝组织病理学表现

纪元

200032 上海市复旦大学附属中山医院病理科

收稿日期:2018-03-14 出版日期:2018-05-10 发布日期:2018-05-25
作者简介:纪元,医学博士,主任医师; 病理科副主任,肝胆胰病理专科主任; 上海市肝病中心病理平台主任; 现任中国医师协会胰腺病委员会神经内分泌肿瘤专业委员会副主任委员,抗癌协会肿瘤病理专业委员会肝癌学组副组长,抗癌协会肝癌专业委员会病理学组委员兼学术秘书,中国实验医学病理专业委员会常委,抗癌协会胰腺癌专业委员会神经内分泌肿瘤学组委员,中国医学促进会神经内分泌肿瘤分会委员; 在肿瘤病理、分子病理、肝胆胰疾病病理和移植病理方面有深厚的造诣,获得上海市医学科技二等奖和上海市科技进步三等奖多项, 主编《肝胆胰肿瘤-临床、影像与病理》,获得上海市科技出版基金和国家科技出版基金资助,荣获华东地区科技出版一等奖; E-mail:Ji.yuan@zs-hospital.sh.cn

Clinical and histopathological features of patients with idiopathoc noncirrhotic portal hypertension

Ji Yuan

Department of Pathology,Zhongshan Hospital, Fudan University,Shanghai 200032,China

Received:2018-03-14 Online:2018-05-10 Published:2018-05-25

摘要/Abstract

关键词: 隐源性非硬化性门脉高压症, 临床特征, 组织病理学

Key words: Idiopathoc noncirrhotic portal hypertension, Clinical feature, Pathology

纪元. 隐源性非硬化性门脉高压症患者临床和肝组织病理学表现[J]. 实用肝脏病杂志, 2018, 21(3): 325-328.

Ji Yuan. Clinical and histopathological features of patients with idiopathoc noncirrhotic portal hypertension[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 325-328.

[1] Schouten JN,Garcia-Pagan JC,Valla DC,et al.Idiopathic non cirrhotic portal hypertension. Hepatology,2011,54(3):1071-1081.
[2] Siramolpiwat S,Seijo S,Miquel R,et al.Idiopathic portal hypertension:natural history and long-term outcome. Hepatology, 2014,59(6):2276-2285.
[3] Nicoletti V,Gioia S,Riggio O,et al. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension:description,prevalence and risk factors. Dig Liver Dis,2016 [ahead of print]
[4] Cazals-Hatem D,Hillaire S,Rudler M,et al.Obliterative portal venopathy:portal hypertension is not always present at diagnosis. J Hepatol,2011,54(3):455-461.
[5] Casillas C,Martí-Bonmatí L,Galant J.Pseudotumoral presentation of nodular regenerative hyperplasia of the liver:imaging in five patients including MR imaging. Eur Radiol,1997,7(5):654-658.
[6] Mahamid J,Miselevich I,Attias D,et al.Nodular regenerative hyperplasia associated with idiopathic thrombocytopenic purpura in a young girl:a case report and review of the literature. J Pediatr Gastroenterol Nutr,2005,41(2):251-255.
[7] Hartleb M,Gutkowski K,Milkiewicz P.Nodular regenerative hyperplasia:evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol,2011,17(11):1400-1409.
[8] Furuichi Y,Moriyasu F,Taira J,et al.Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol,2013,48(9):1061-1068.
[9] Khanna R,Sarin SK.Non-cirrhotic portal hypertension: Diagnosis and management. J Hepatol,2014,60(2):421-441.
[10] Pulvirenti F,Pentassuglio I,Milito C,et al.Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. J Immunol Res,2014,2014:672458.
[11] Hillaire S,Bonte E,Denninger MH,et al.Idiopathic non-cirrhotic intra-hepatic portal hypertension in the west:a re-evaluation in 28 patients. Gut,2002,51(2):275-280.
[12] K öksal AS,K öklü S,Ibis M,et al. Clinical features,serum interleukin-6,and interferon-gamma levels of 34 Turkish patients with hepatoportal sclerosis. Dig Dis Sci,2007,52(12):3493.
[13] Cazals-Hatem D,Hillaire S,Rudler M,et al.Obliterative portal venopathy:portal hypertension is not always present at diagnosis. J Hepatol,2011,54(3):455-461.
[14] Goel A,Elias JE,Eapen CE,et al.Idiopathic non-cirrhotic intrahepatic portal hypertension(NCIPH)-newer insights into pathogenesis and emerging newer treatment options. J Clin Exp Hepatol,2014,4(3):247-256.
[15] Marzano M,Cazals-Hatem D,Rautou PE,et al.The significance of nonobstructive sinusoidal dilatation of the liver: impaired portal perfusion or inflammatory reaction syndrome. Hepathology,2015,62(3):956-963.

隐源性非硬化性门脉高压症患者临床和肝组织病理学表现

Clinical and histopathological features of patients with idiopathoc noncirrhotic portal hypertension

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴欣, 郭杨志, 杜霄壤, 吴孟晋, 朱云, 冯兴中. 75例中药诱导的肝损伤患者临床特征分析*[J]. 实用肝脏病杂志, 2019, 22(5): 668-671.
[2]	蒋奕,刘冰. 慢性乙型肝炎与慢性丙型肝炎患者临床和肝组织病理学特征分析[J]. 实用肝脏病杂志, 2019, 22(2): 188-191.
[3]	林兰,沈敏,阮健文. 自身免疫性肝炎患者肝组织程序性死亡受体1表达及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(2): 204-207.
[4]	宋芳娇,朱冰,吕飒,田华,王海波,辛绍杰,游绍莉. 314例药物性肝衰竭患者临床特征分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 216-219.
[5]	郭宝娜, 展玉涛. 酒精性肝病79例临床特征分析[J]. 实用肝脏病杂志, 2018, 21(6): 877-880.
[6]	肖贵宝. 不同年龄和血清HBV DNA水平慢性乙型肝炎患者肝组织病理学变化*[J]. 实用肝脏病杂志, 2018, 21(2): 277-278.
[7]	何志颖, 赵新颜. 肝组织病理学检查在不明原因肝病诊治中的应用[J]. 实用肝脏病杂志, 2018, 21(1): 10-13.
[8]	张勋, 孙秋林, 李家斌. 散发性戊型肝炎156例临床分析[J]. 实用肝脏病杂志, 2017, 20(6): 705-708.
[9]	韩彦青，叶飘，石境懿. 低出生体质量胆汁淤积儿临床特征和结局随访研究[J]. 实用肝脏病杂志, 2017, 20(5): 588-591.
[10]	黄艳艳，林书典，詹锋，何周桃. 狼疮性肝损伤患者临床特征调查[J]. 实用肝脏病杂志, 2017, 20(5): 610-611.
[11]	王琨，王翠秀，王秀. 新生儿肝内胆汁淤积症与胆道闭锁临床特征比较[J]. 实用肝脏病杂志, 2017, 20(2): 228-229.
[12]	姚云洁, 肖朗, 杨才兴, 卢林, 刘鸿凌. 中草药所致DILI患者临床和肝组织病理学特点分析[J]. 实用肝脏病杂志, 2016, 19(4): 441-444.
[13]	郝建宏,郝海燕,胡忆玲. 94例原发性胆汁性肝硬化临床特征分析[J]. 实用肝脏病杂志, 2016, 19(3): 352-353.
[14]	魏革，罗婷，徐岩，关亦兵. 126例儿童非常见病毒性肝炎肝损害病因及临床特征分析[J]. 实用肝脏病杂志, 2015, 18(6): 667-668.
[15]	陈韬，叶昊，方文敏，吴亮，黄元成. 肝豆状核变性与慢性乙型肝炎重度患者临床特征分析^*[J]. 实用肝脏病杂志, 2015, 18(5): 486-490.